Understanding the biology of melanoma heterogeneity with a goal to improve therapies. #tumor_spheroids #microscopy #scitweets #FUCCI
Joined August 2018
- Tweets 867
- Following 418
- Followers 864
- Likes 2,750
166 Photos and videos
Hidden Architecture of Resistance: The Extracellular Matrix in Melanom… sciencedirect.com/science/ar…
32
immedicohospitalario.es/noti…
Zeng, Gandini et al. (2026)
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer 134: 1830–1840
17
rdcu.be/fokWq
Zeng, Gandini et al. (2026)
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer 134: 1830–1840
PMID: 41946828; doi: 10.1038/s41416-026-03416-y
12
rdcu.be/fokWq
Zeng, Gandini et al. (2026)
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.
Br J Cancer 134: 1830–1840
PMID: 41946828; doi: 10.1038/s41416-026-03416-y
36
Hui SY, Jain R, Haass NK, Weninger W, Tikoo S, Guo D (2026)
The Emerging Melanoma Management: Historical Perspective to Future Directions.
Cancers 18: 968
PMID: 41899570; doi: 10.3390/cancers18060968https://www.mdpi.com/3792592
27
19 Dec 2024
Hot off the press! Congrats to Sanket, @LukeJohnsonLab and their team and collaborators - fantastic work!
Raut SB, Joly F, Haass NK, Eri R, Canales JJ, Benedek DM, Ursano RS, Johnson LR (2024). Transl Psychiatry 14: 492
doi: doi.org/10.1038/s41398-024-0…
1
172
25 Nov 2024
NHMRC results are out "Under Embargo". Yes we know that the Australian Government is only interested in mining and footy, but not in science and the arts. So, why Embargo?!
3
669
4 Nov 2024
Do you remember the four years (Jan 2017-Jan 2021) of chaos, destruction and disaster? Not again!
If you love democracy, unity, human rights, peace and our precious environment, please vote for Kamala Harris!
2 Nov 2024
This video is incredible.
Everyone should RETWEET it so the whole *world* sees it.
1
342
23 Oct 2024
Today!
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
10
521
Haass_Melanoma_lab retweeted
TRI explored melanoma, the immune system, prostate, bladder and childhood brain cancer - as part of a mini-symposium today. Thanks Dr Mitchell Lawrence at @MonashUni, @srilakshmisri13, @HaassLab, Elysse Morris, Dr Liam O'Brien, @OzEDW, @BockNat. @QUT, @UQ_News, @MaterResearch.
1
7
1,732
16 Sep 2024
Long week: #FrazerInstUQ @UQMedicine HDR retreat on Monday and Tuesday on Minjerribah, and Skin Cancer 2024 conference from Wednesday through to Sunday at the BCEC! skincancer2024.org/
7
240
Haass_Melanoma_lab retweeted
10 Sep 2024
🎁Interested in reading more about the study? Here is the Research Briefing describing the authors' and an expert's view, but also the editor's perspective on the findings and their importance. #microtubule #mechanobiology
👉🏽rdcu.be/dTAaS
nature.com/articles/s41556-0…
2
10
2,023
10 Sep 2024
10 Sep 2024
💫NEW: @SamStehbens, @robertr33 & co show that during 3D #CellMigration, compression recruits cytoplasmic linker-associated proteins to #microtubules, which coordinate nuclear positioning and contractility in confined migration.
👉🏼rdcu.be/dTz7u
nature.com/articles/s41556-0…
2
338
6 Sep 2024
IUBP-MEPSA World Congress, 25th-30th August 2024, Perth.
We certainly cannot say that we didn't know better back then.
1
1
221
Haass_Melanoma_lab retweeted
4 Sep 2024
Team science wins again. This project epitomises what can be achieved when the right group of people are proud together. Huge congratulations to @MelanomaACEMID team!!
4 Sep 2024
🏆 ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis @MelanomaACEMID @UQMedicine is awarded the @BizEventsPerth Eureka Prize for Excellence in Interdisciplinary Scientific Research. #EurekaPrizes
Learn more: youtu.be/VV7x9SlGupw
4
30
1,117
6 Sep 2024
IUBP-MEPSA World Congress 2024, Perth.
Session "Melanoma heterogeneity and therapeutic approaches" on the 27th August 2024. @TheStarkLab, #FrazerInstUQ, @UQMedicine; @vivianchualah, @EdithCowanUni; Peter Lau, @PerkinsComms; @HaassLab, #FrazerInstUQ, @UQMedicine
5
515
23 Aug 2024
#FrazerInstUQ @UQMedicine HDR Minisymposium today. Great talks, great discussion. People's choice best talk award goes to Marion Barros @SimpsonTeamUQ. Runner-up was Daniel Butcher @YUmmunology. Congratulations!
11
337
Haass_Melanoma_lab retweeted
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
1
7
705
Haass_Melanoma_lab retweeted
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
1
7
132
Haass_Melanoma_lab retweeted
19 Jul 2024
Great talk by A/Prof Aideen McInerney-Leo, from UQ, about the importance of Mainstreaming Melanoma Genetic Testing in Australia. @Amcinerneyleo @AsdrResearch @CTSR_USyd
5
13
385